Biosimilar Newsletter Archive

  1. 08.19.21 -- How To Select The Best Human Factors Method For Your Drug Device 8/19/2021
    08/19/21 Biosimilar Development Newsletter
  2. 08.12.21 -- Patent Transparency: The Revamped Purple Book 8/12/2021
    08/12/21 Biosimilar Development Newsletter
  3. 08.11.21 -- Enhancing Delivery For Oral Solids 8/11/2021

    08/11/21 Biosimilar Development Newsletter

  4. 08.11.21 -- New Podcast Alert! Cell and Gene: The Podcast 8/11/2021
    08/11/21 Biosimilar Development Newsletter
  5. 08.10.21 -- Start Your Automation Journey And Get To Market Faster - One Step At A Time 8/10/2021

    08/10/21 Biosimilar Development Newsletter

  6. 08.05.21 -- How To Enhance "Operational Learning" In Biopharma 8/5/2021
    08/05/21 Biosimilar Development Newsletter
  7. 07.30.21 -- Committing To Combination Product Success: De-Risking Development And Delivery 7/30/2021

    07/30/21 Biosimilar Development Newsletter

  8. 07.29.21 -- Navigating DSCSA Implementation: 4 New FDA Guidances 7/29/2021
    07/29/21 Biosimilar Development Newsletter
  9. 07.28.21 -- Technologies And Advancements In Vaccine Manufacturing Platforms 7/28/2021
    07/28/21 Biosimilar Development Newsletter
  10. 07.22.21 -- New U.S. Legislation Creates Biosimilars Momentum 7/22/2021
    07/22/21 Biosimilar Development Newsletter